
|Articles|August 15, 2018
Podcast: Discussing the ARRIVE trial results
Dr. Charles J. Lockwood sits down with Linda Marie Wetzel, Executive Editor for Contemporary OB/GYN, to discuss the results of the ARRIVE study and what these findings mean for ob/gyns and their patients.
Advertisement
ARRIVE podcast
Dr. Charles J. Lockwood sits down with Contemporary OB/GYN to discuss the results of the ARRIVE trial and what these findings mean for ob/gyns and their patients.
Newsletter
Get the latest clinical updates, case studies, and expert commentary in obstetric and gynecologic care. Sign up now to stay informed.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Contemporary OB/GYN
1
FDA approves elinzanetant (Lynkuet) for vasomotor menopausal symptoms
2
Estrogen therapy shows mixed mental health effects in menopause
3
Earlier menopause, reduced cardiac function jointly linked to poorer brain health in women
4
Elinzanetant demonstrates favorable safety profile in menopausal women, with James A. Simon, MD
5




















